Home Biosimilar Antibodies Immunology & Inflammation Immunology & Inflammation related inhibitor -PD-1/PD-L1 antibody Erfonrilimab (Anti-CTLA4 & PD-L1) For research use only.
Not for use in humans.

Erfonrilimab (Anti-CTLA4 & PD-L1)

Synonyms: KN 046

Erfonrilimab is a humanized bispecific monoclonal antibody directed against programmed cell death-1 ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. It is used to treat solid tumors and exhibits promising efficacy in advanced non-small cell lung cancer (NSCLC) patients who had experienced failure or intolerance to prior platinum-based chemotherapy. MW: 107.44 KD.

Erfonrilimab (Anti-CTLA4 & PD-L1)

Purity & Quality Control

Choose Selective Immunology & Inflammation related Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Erfonrilimab is a humanized bispecific monoclonal antibody directed against programmed cell death-1 ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. It is used to treat solid tumors and exhibits promising efficacy in advanced non-small cell lung cancer (NSCLC) patients who had experienced failure or intolerance to prior platinum-based chemotherapy. MW: 107.44 KD.

Product Details

CAS No. 2367013-69-0
Source CHO
Storage
(From the date of receipt)		 -80℃

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Erfonrilimab (Anti-CTLA4 & PD-L1) | Erfonrilimab (Anti-CTLA4 & PD-L1) supplier | purchase Erfonrilimab (Anti-CTLA4 & PD-L1) | Erfonrilimab (Anti-CTLA4 & PD-L1) cost | Erfonrilimab (Anti-CTLA4 & PD-L1) manufacturer | order Erfonrilimab (Anti-CTLA4 & PD-L1) | Erfonrilimab (Anti-CTLA4 & PD-L1) distributor